The pharmaceutical company said, “The allegations that came out in the media are entirely baseless, distorted, and part of a smear campaign" ...

Beximco Pharmaceuticals, and Shinepukur Ceramics to resume their duties. The Bangladesh Securities and Exchange Commission (BSEC) appointed 11 independent directors to the three listed companies ...

The High Court on Wednesday directed the Bangladesh Bank and other relevant authorities to take legal action against ...

The same order also directed Bangladesh Bank to take necessary steps to recover funds taken from different banks by Beximco Pharmaceuticals Limited’s founder Salman F Rahman and repatriate any ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

No receiver will be appointed to oversee all entities of Beximco Group, owned by Salman F Rahman, as they will operate under their supervision with strict monitoring by Bangladesh Bank and other ...

Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Ascendis Pharma (ASND – Research Report) today and set a price target of $180.00. The company’s shares closed last Friday at ...

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on aTyr Pharma (ATYR – Research Report) today and set a price target of $20.00. The company’s shares closed yesterday at $3.99.

NASHVILLE, Tenn., Feb. 25, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its annual 2024 financial ...